100 related articles for article (PubMed ID: 29160106)
21. Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein.
Kato S; Inoue K; Kobayashi K; Yasoshima Y; Miyachi S; Inoue S; Hanawa H; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2007 Nov; 18(11):1141-51. PubMed ID: 17944573
[TBL] [Abstract][Full Text] [Related]
22. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
[TBL] [Abstract][Full Text] [Related]
23. Kinetic analyses of stability of simple and complex retroviral vectors.
Higashikawa F; Chang L
Virology; 2001 Feb; 280(1):124-31. PubMed ID: 11162826
[TBL] [Abstract][Full Text] [Related]
24. Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins.
Liu H; Wu R; Yuan L; Tian G; Huang X; Wen Y; Ma X; Huang Y; Yan Q; Zhao Q; Cao S; Wen X
Virus Res; 2017 Feb; 229():9-16. PubMed ID: 27993624
[TBL] [Abstract][Full Text] [Related]
25. Functional pseudotyping of human immunodeficiency virus type 1 vectors by Western equine encephalitis virus envelope glycoprotein.
Poluri A; Ainsworth R; Weaver SC; Sutton RE
J Virol; 2008 Dec; 82(24):12580-4. PubMed ID: 18842711
[TBL] [Abstract][Full Text] [Related]
26. Production of Retrovirus-Based Vectors in Mildly Acidic pH Conditions.
Holic N; Fenard D
Methods Mol Biol; 2016; 1448():41-8. PubMed ID: 27317171
[TBL] [Abstract][Full Text] [Related]
27. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.
Kumar M; Bradow BP; Zimmerberg J
Hum Gene Ther; 2003 Jan; 14(1):67-77. PubMed ID: 12573060
[TBL] [Abstract][Full Text] [Related]
28. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
[TBL] [Abstract][Full Text] [Related]
29. Thermosensitivity of the reverse transcription process as an inactivation mechanism of lentiviral vectors.
Carmo M; Dias JD; Panet A; Coroadinha AS; Carrondo MJ; Alves PM; Cruz PE
Hum Gene Ther; 2009 Oct; 20(10):1168-76. PubMed ID: 19537947
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral Vectors Pseudotyped with Filoviral Glycoproteins.
Sinn PL; Coffin JE; Ayithan N; Holt KH; Maury W
Methods Mol Biol; 2017; 1628():65-78. PubMed ID: 28573611
[TBL] [Abstract][Full Text] [Related]
31. Pseudo-typed Semliki Forest virus delivers EGFP into neurons.
Jia F; Miao H; Zhu X; Xu F
J Neurovirol; 2017 Apr; 23(2):205-215. PubMed ID: 27739033
[TBL] [Abstract][Full Text] [Related]
32. Jaagsiekte sheep retrovirus pseudotyped lentiviral vector-mediated gene transfer to fetal ovine lung.
Davey MG; Zoltick PW; Todorow CA; Limberis MP; Ruchelli ED; Hedrick HL; Flake AW
Gene Ther; 2012 Feb; 19(2):201-9. PubMed ID: 21654824
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.
Chakkaramakkil Verghese S; Goloviznina NA; Kurre P
Stem Cell Res Ther; 2016 Nov; 7(1):170. PubMed ID: 27865213
[TBL] [Abstract][Full Text] [Related]
34. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
35. Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow.
Pan D; Gunther R; Duan W; Wendell S; Kaemmerer W; Kafri T; Verma IM; Whitley CB
Mol Ther; 2002 Jul; 6(1):19-29. PubMed ID: 12095299
[TBL] [Abstract][Full Text] [Related]
36. Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein.
Höfig I; Barth S; Salomon M; Jagusch V; Atkinson MJ; Anastasov N; Thirion C
Biomaterials; 2014 Apr; 35(13):4204-12. PubMed ID: 24529898
[TBL] [Abstract][Full Text] [Related]
37. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.
Watson DJ; Kobinger GP; Passini MA; Wilson JM; Wolfe JH
Mol Ther; 2002 May; 5(5 Pt 1):528-37. PubMed ID: 11991743
[TBL] [Abstract][Full Text] [Related]
38. Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9.
Pichlmair A; Diebold SS; Gschmeissner S; Takeuchi Y; Ikeda Y; Collins MK; Reis e Sousa C
J Virol; 2007 Jan; 81(2):539-47. PubMed ID: 17079284
[TBL] [Abstract][Full Text] [Related]
39. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.
Yang Y; Vanin EF; Whitt MA; Fornerod M; Zwart R; Schneiderman RD; Grosveld G; Nienhuis AW
Hum Gene Ther; 1995 Sep; 6(9):1203-13. PubMed ID: 8527479
[TBL] [Abstract][Full Text] [Related]
40. Influence of mildly acidic pH conditions on the production of lentiviral and retroviral vectors.
Holic N; Seye AK; Majdoul S; Martin S; Merten OW; Galy A; Fenard D
Hum Gene Ther Clin Dev; 2014 Sep; 25(3):178-85. PubMed ID: 25073060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
